Treatment for selective weight control

Details Treatment for selective weight control Treatment for selective weight control

A - Human Necessities

61

K

167/179

A61K 31/48 (2006.01) A61K 31/135 (2006.01) A61K 31/245 (2006.01) A61K 31/41 (2006.01) A61K 31/475 (2006.01) A61K 31/52 (2006.01) A61K 47/00 (2006.01)

Patent

CA 1228026

-1- TREATMENT FOR SELECTIVE WEIGHT CONTROL ABSTRACT OF THE DISCLOSURE A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.

442630

Affiliated with

Also associated with

Rating

Treatment for selective weight control does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for selective weight control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for selective weight control will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1293230